Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Daily News

Dimitrios Karmpaliotis, Master Operator and Mentor With ‘Heart of Gold,’ Dies at 53

Yael L. Maxwell

June 09, 2025

News Daily News

Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry

Caitlin E. Cox

June 09, 2025

News Conference News SCAI 2025

Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers

L.A. McKeown

May 07, 2025

News Conference News ACC 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

Caitlin E. Cox

March 31, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Conference News STS 2025

With Limited RCTs of Arterial Grafting, Researchers Take a Different Tack

Yael L. Maxwell

January 31, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

Advertisement

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Dimitrios Karmpaliotis, Master Operator and Mentor With ‘Heart of Gold,’ Dies at 53

Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry

Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

With Limited RCTs of Arterial Grafting, Researchers Take a Different Tack

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content